Latest article
Lilly’s tirzepatide beats Ozempic in head-to-head kind 2 diabetes trial
Eli Lilly announced that its investigated GIP and GLP-1 inhibitor tirzepatide has demonstrated superiority over Novo Nordisk's Ozempic in a Phase III study.The SURPASS-2...
Sugar highs ‘n’ lows: 5 sugar-free recipes to fulfill your candy tooth
Many of us enjoy treats like ice cream, cookies, donuts, candy, and other candies, but the refined sugars and high fructose corn syrup that...
Again To College Diet Made Straightforward
Posted: Aug 24, 2021 / 8:56 AM EDT / Updated: Aug 24, 2021 / 8:56 AM EDT
Back to school is busy, but registered nutritionist...